Results: Nausea, vomiting, diarrhea, and constipation were the most frequently reported GI adverse events, generally dose-dependent and transient
Member States are also encouraged (together with experts and learned societies) to develop guidelines to facilitate prioritisation of patients who have the greatest need for the medicines
Quentin Clemens, M.D., University of Michigan
Table of Contents The Drug That Kept Becoming Something Else The Joint Surprise Liver and Alcohol Why Tirzepatide and Not Pure GLP-1 This Is the Bet I am Making Why Not Retatrutide What It Has Done for Me Safety Concerns Micronutrients References The Drug That Kept Becoming Something Else When John Eng found GLP-1 in the saliva of the Gila monster in the early 1990s, all it was supposed to do was lower blood sugar
Ueda S, Kitazawa S, Ishida K, Nishikawa Y, Matsui M, Matsumoto H, Aoki T, Nozaki S, Takeda T, Tamori Y, Aiba A, Kahn CR, Kataoka T, Satoh T (2010) Crucial role of the small GTPase Rac1 in insulin-stimulated translocation of glucose transporter 4 to the mouse skeletal muscle sarcolemma
The Cigna Group will also provide additional disclosures regarding its PBM business in its upcoming SEC 10-Q filing
